RareMed's Remarkable Growth Journey
RareMed, a leader in patient support and access solutions for complex therapies, has achieved incredible success that has captivated the attention of the Pittsburgh business community. Recently recognized by the Pittsburgh Business Times as the Fastest Growing Company in the city, RareMed's journey is not just about rapid expansion—it's about smart, strategic growth.
A Strategic Approach to Growth
The accolade was presented at the publication's annual Fast 50 awards, with RareMed being celebrated for its noteworthy achievements between 2022 and 2024. This is the fourth consecutive year the company has earned a spot as a finalist in this competitive arena. RareMed's growth story reflects a deliberate approach, emphasizing the importance of partnerships and values that prioritize patient satisfaction and team welfare.
Commitment to Quality and Culture
President Dr. Douglas Gebhard, who attended the awards ceremony along with nearly two dozen members of Team RareMed, expressed gratitude and humility during his remarks. He emphasized that the company's growth is a result of a well-orchestrated strategy aligning with its mission to enhance patient care while maintaining quality and culture. This calculated expansion has allowed RareMed to increase patient satisfaction while avoiding the pitfalls of uncontrolled growth.
Exceptional Achievements and Recognition
Dr. Gordon Vanscoy, RareMed's Chairman and CEO, spoke about the achievements since the company's inception seven years ago. Ratifying the growth rate, RareMed achieved a staggering 359% revenue increase from 2022 to 2024, translating to a 189% compound annual growth rate. This outstanding performance earned RareMed the #1 spot in the Fast 50, with previous rankings highlighting their consistent upward trajectory.
Patient Satisfaction at the Core
RareMed's philosophy revolves around patient and team member satisfaction. Dr. Douglas Gebhard reiterated that their focus remains on being recognized for patient care and the quality of their workplace culture rather than just revenue growth. As Dr. Gebhard noted, "We’re humbled to achieve this honor by doing it the right way—our reputation for care truly speaks for itself."
Honors and Awards
Recently, RareMed was honored with MMIT's Patient Choice Award for 2025, signifying their position as the highest-rated specialty pharmacy concerning patient satisfaction over the past three years. Their commitment was exemplified by an extraordinary perfect net promoter score in Q1 2025. Additionally, the company has routinely been recognized as a finalist in various national awards, reinforcing its status as a top workplace and community leader.
Looking Ahead
Following the recognition at the Fast 50 ceremony, the Pittsburgh Business Times published an article praising RareMed's reputation-driven journey. Evan Rosenberg, Market President, acknowledged that RareMed's growth is a result of their unwavering commitment to excellence in both patient care and operational achievement. Dr. Vanscoy reiterated the importance of collaboration with the Pittsburgh Business Times and local leaders in fostering regional economic growth.
Future Goals
As RareMed looks to the future, the focus remains on collaborative growth, selecting the right partners, and investing in their talented workforce. Their mantra of providing quality patient care is coupled with an unwavering belief that with this approach, further growth will naturally follow. RareMed's story is a reminder that success in business comes with a focus on the things that truly matter—quality, integrity, and relationships.
Frequently Asked Questions
What does RareMed specialize in?
RareMed specializes in patient support and access solutions for complex therapies.
What accolade did RareMed recently receive?
RareMed was recognized as the Fastest Growing Company in Pittsburgh by the Pittsburgh Business Times.
How much revenue growth did RareMed achieve from 2022 to 2024?
RareMed achieved a revenue growth of 359% during that period.
What is the company’s focus beyond growth?
RareMed emphasizes patient satisfaction and team member satisfaction, prioritizing care over mere revenue growth.
What recent award did RareMed win for patient satisfaction?
RareMed was awarded the MMIT’s Patient Choice Award for 2025, reflecting high patient satisfaction scores.
